Tradestie Institutional Equity Comparison Engine

ANNX vs VIR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

VIR Overall Edge

VIR Captures Institutional Edge (2โ€“2 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Vir Biotechnology, Inc. Common Stock (VIR) driven by superior Valuation, Momentum & Technical while ANNX counters with relative strength in Growth & Margin, Options & Structure. Fundamentally, ANNX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus VIR at 4.3x Forward P/E and -70.2% operating margin (+19582.5% YoY). In options structure, ANNX sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro) against VIR sits in BREAKDOWN (5th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner VIR
ANNX N/M vs VIR 4.3x Fwd P/E
Growth & Margin Winner ANNX
Op Margin 0.0% vs -70.2% ยท YoY +0.0% vs +19582.5%
Momentum & Technical Winner VIR
1Y +28.6% vs +64.3% ยท 52W Pos 18% vs 43%
Options & Structure Winner ANNX
BREAKDOWN (100th %ile IV) vs BREAKDOWN (5th %ile IV)
ANNX NASDAQ
Annexon, Inc. Common Stock
Pharmaceutical Preparations
$3.48
-2.38% 1D
Market Cap $747.8M
1M Return -13.09%
1Y Return +28.6%
Forward P/E N/M
Unified AI Score
43.5 / 100 HOLD
Tech 37.0 Fund 55.0 Flow 72.0 Mom 60.0
VIR NASDAQ
Vir Biotechnology, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$9.25
-3.44% 1D
Market Cap $1.7B
1M Return -9.4%
1Y Return +64.3%
Forward P/E 4.3x
Unified AI Score
46.2 / 100 HOLD
Tech 37.0 Fund 54.0 Flow 67.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ANNX +28.6% VIR +64.3% Spread: +35.7 pp (VIR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ANNX TTM Op. Margin: 0.0% VIR TTM Op. Margin: -70.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ANNX vs VIR. Trailing 12-month operating profitability (ANNX 0.0% vs VIR -70.2%) and valuation multiples (ANNX N/M vs VIR 4.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ANNX (3) vs VIR (7)
Institutional Metric ANNX VIR Criterion Row Winner
Market Capitalization Scale $747.8M $1.7B Larger Scale VIR
Trailing P/E Ratio Valuation N/M 4.3x Lower Multiple VIR
Forward P/E Ratio Valuation N/M 4.3x Lower Multiple VIR
Revenue Growth (YoY) Growth +0.0% +19582.5% Higher Growth VIR
Operating Margin (TTM) Profitability 0.0% -70.2% Higher Margin ANNX
Net Profit Margin Profitability 0.0% -61.0% Higher Margin ANNX
Return on Equity (ROE) Capital Efficiency -130.8% -21.8% Higher ROE VIR
52-Week Range Position Momentum 18% ($3โ€“$7) 43% ($5โ€“$14) Stronger Trend VIR
Beta / 30D Volatility Risk Regime 1.69ฮฒ ยท 63% Vol 1.75ฮฒ ยท 101% Vol Lower Realized Risk ANNX
Unified Institutional Score Composite Signal 43.5 / 100 (HOLD) 46.2 / 100 (HOLD) Higher Composite VIR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ANNX vs VIR Buy Guide
ANNX BREAKDOWN
88d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live ANNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VIR BREAKDOWN
6d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live VIR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ANNX nor VIR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.